Stockscreener 앱 받기
5.54
4.14%
0.22
시장 영업 전:
5.41
-0.13
-2.35%
전일 마감가:
$5.32
열려 있는:
$5.33
하루 거래량:
3.23M
Relative Volume:
0.77
시가총액:
$745.54M
수익:
-
순이익/손실:
$-217.44M
주가수익비율:
-2.553
EPS:
-2.17
순현금흐름:
$-205.20M
1주 성능:
+2.78%
1개월 성능:
+70.99%
6개월 성능:
+178.39%
1년 성능:
+43.15%
1일 변동 폭
$5.28
$5.63
1주일 범위
$4.87
$5.63
52주 변동 폭
$1.11
$5.63
Prime Medicine Inc Stock (PRME) Company Profile
명칭
Prime Medicine Inc
전화
617-465-0013
주소
60 FIRST ST., CAMBRIDGE
PRME을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
5.54 | 948.42M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-20 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-05-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-10 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-20 | 개시 | H.C. Wainwright | Buy |
| 2024-05-16 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-22 | 개시 | Chardan Capital Markets | Buy |
| 2024-04-08 | 개시 | TD Cowen | Buy |
| 2024-04-03 | 개시 | Wedbush | Outperform |
| 2024-01-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-08 | 개시 | Citigroup | Neutral |
| 2023-10-09 | 개시 | BMO Capital Markets | Outperform |
| 2023-07-31 | 개시 | Guggenheim | Buy |
| 2023-04-18 | 개시 | Stifel | Buy |
| 2022-11-14 | 개시 | Goldman | Neutral |
| 2022-11-14 | 개시 | JP Morgan | Overweight |
| 2022-11-14 | 개시 | Jefferies | Buy |
| 2022-11-14 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Prime Medicine Inc 주식(PRME)의 최신 뉴스
Prime Medicine (NASDAQ:PRME) Hits New 1-Year HighTime to Buy? - MarketBeat
Prime Medicine (NASDAQ:PRME) Shares Up 3.9%Here's Why - MarketBeat
Short interest data insights for Prime Medicine Inc.Market Performance Recap & Weekly Return Optimization Alerts - newser.com
What earnings revisions data tells us about Prime Medicine Inc.Take Profit & Real-Time Chart Pattern Alerts - newser.com
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
Is Prime Medicine Inc. stock a buy on dips2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Is Prime Medicine Inc. stock entering bullish territoryTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Using flow based indicators on Prime Medicine Inc.Quarterly Trade Review & Safe Capital Investment Plans - newser.com
Prime Medicine, Inc. Hits New 52-Week High of $5.20 - Markets Mojo
Prime Medicine (NASDAQ:PRME) Stock Price Down 5.6%What's Next? - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 5.1%What's Next? - MarketBeat
Goldman Sachs Group Inc. Lowers Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat
Prime Medicine Stock Soars 8.02%, Hits Intraday High of $5.43 - Markets Mojo
Prime Medicine, Inc. Hits New 52-Week High of $5.63 - Markets Mojo
Prime Medicine (NASDAQ:PRME) Shares Gap DownTime to Sell? - MarketBeat
Prime Medicine, Inc. $PRME Shares Purchased by Palumbo Wealth Management LLC - MarketBeat
Prime Medicine Unveils New Prime Editing Advancements - MSN
Prime Medicine, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Prime Medicine (NASDAQ:PRME) Hits New 12-Month HighWhat's Next? - MarketBeat
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME) - Seeking Alpha
What machine learning models say about Prime Medicine Inc.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Stock Traders Buy Large Volume of Call Options on Prime Medicine (NYSE:PRME) - MarketBeat
Prime Medicine (NASDAQ:PRME) Reaches New 52-Week HighHere's Why - MarketBeat
Prime Medicine (NYSE:PRME) Trading 5.4% HigherShould You Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Shares Gap UpStill a Buy? - MarketBeat
Tech Rally: Should I trade or invest in Prime Medicine IncBond Market & Stepwise Swing Trade Plans - خودرو بانک
Prime Medicine (PRME): Evaluating Valuation After Recent LNP Innovations Spotlighted at Cell & Gene Therapy Conference - Yahoo Finance
Prime Medicine (NASDAQ:PRME) Trading 12.7% HigherShould You Buy? - MarketBeat
VIX Spike: Why is Prime Medicine Inc. stock going upWeekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک
Meme Stocks: Is Prime Medicine Inc. backed by strong institutional buyingEarnings Summary Report & AI Enhanced Trading Signals - خودرو بانک
Panic Selling: Can Prime Medicine Inc. reach resistance levels soonPortfolio Gains Summary & High Accuracy Buy Signal Tips - خودرو بانک
Prime Medicine (NASDAQ:PRME) Shares Gap UpShould You Buy? - MarketBeat
S P Trends: Is Prime Medicine Inc. stock a smart retirement pick2025 Key Lessons & Real-Time Stock Price Movement Reports - khodrobank.com
Will Prime Medicine Inc stock hit new highs in YEARAnalyst Downgrade & Growth Oriented Trade Recommendations - khodrobank.com
Will Prime Medicine's (PRME) Innovation Messaging at CGTI Drive Lasting Competitive Advantage? - Yahoo Finance
Quarterly Earnings: What is Prime Medicine Inc.’s market position2025 Big Picture & High Accuracy Swing Entry Alerts - خودرو بانک
Prime Medicine, Inc. (NYSE:PRME) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Market Outlook: Is Prime Medicine Inc. forming higher highs and higher lowsQuarterly Growth Report & Breakout Confirmation Alerts - خودرو بانک
Fed Watch: What is the target price for Prime Medicine Inc stockTrade Exit Summary & Daily Price Action Insights - خودرو بانک
Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?) - yahoo.com
Merger Talk: What is Prime Medicine Inc.’s market position2025 Risk Factors & Verified Short-Term Plans - khodrobank.com
Stop Loss: Why is Prime Medicine Inc. stock going upWeekly Trade Report & Fast Gain Swing Trade Alerts - khodrobank.com
What is Prime Medicine Inc. s revenue forecastQuarterly Trade Summary & Expert Verified Movement Alerts - خودرو بانک
Head-To-Head Analysis: Prime Medicine (NYSE:PRME) and Big Cypress Acquisition (OTCMKTS:BCYP) - Defense World
What the charts say about Prime Medicine Inc. todayStock Surge & Low Drawdown Momentum Ideas - newser.com
Comparing Prime Medicine (NASDAQ:PRME) & Vor Biopharma (NASDAQ:VOR) - Defense World
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN
Is Prime Medicine Inc. backed by strong institutional buyingStop Loss & Free High Accuracy Swing Entry Alerts - Lancaster City Council
Prime Medicine Inc. Breaks Losing Streak — Is the Trend ReversingJuly 2025 Institutional & Smart Allocation Stock Tips - beatles.ru
Prime Medicine (NASDAQ:PRME) Stock Price Down 3.7% After Analyst Downgrade - MarketBeat
Prime Medicine Inc (PRME) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):